Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab? (Q33830113)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab? |
scientific article |
Statements
1 reference
Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab? (English)
1 reference
F Stephen Hodi
1 reference
Mizuki Nishino
1 reference
Maria Gargano
1 reference
Margaret Suda
1 reference
Nikhil H Ramaiya
1 reference
18 June 2014
1 reference
1 reference
17
1 reference
Identifiers
1 reference
1 reference
1 reference
1 reference